Iron overload accelerates neuronal amyloid-β production and cognitive impairment in transgenic mice model of Alzheimer's disease

Iron dyshomeostasis is proving increasingly likely to be involved in the pathology of Alzheimer's disease (AD); yet, its mechanism is not well understood. Here, we investigated the AD-related mechanism(s) of iron-sulfate exposure in vitro and in vivo, using cultured primary cortical neurons and APP/PS1 AD-model mice, respectively. In both systems, we observed iron-induced disruptions of amyloid precursor protein (APP) processing, neuronal signaling, and cognitive behavior. Iron overload increased production of amyloidogenic KPI-APP and amyloid beta. Further, this APP misprocessing was blocked by MK-801 in vitro, suggesting the effect was N-methyl-D-aspartate receptor (NMDAR) dependent. Calcium imaging confirmed that 24 hours iron exposure led to disrupted synaptic signaling by augmenting GluN2B-containing NMDAR expression-GluN2B messenger RNA and protein levels were increased and promoting excessing extrasynaptic NMDAR signaling. The disrupted GluN2B expression was concurrent with diminished expression of the splicing factors, sc35 and hnRNPA1. In APP/PS1 mice, chronic iron treatment led to hastened progression of cognitive impairment with the novel object recognition discrimination index, revealing a deficit at the age of 4 months, concomitant with augmented GluN2B expression. Together, these data suggest iron-induced APP misprocessing and hastened cognitive decline occur through inordinate extrasynaptic NMDAR activation.

[1]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[2]  S. Snyder,et al.  NMDA Receptor-Nitric Oxide Transmission Mediates Neuronal Iron Homeostasis via the GTPase Dexras1 , 2006, Neuron.

[3]  C. Spilker,et al.  Encoding and Transducing the Synaptic or Extrasynaptic Origin of NMDA Receptor Signals to the Nucleus , 2013, Cell.

[4]  F. Codazzi,et al.  Iron handling in hippocampal neurons: activity‐dependent iron entry and mitochondria‐mediated neurotoxicity , 2011, Aging cell.

[5]  H. Bading,et al.  Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways , 2002, Nature Neuroscience.

[6]  G. Westbrook,et al.  The Incorporation of NMDA Receptors with a Distinct Subunit Composition at Nascent Hippocampal Synapses In Vitro , 1999, The Journal of Neuroscience.

[7]  Tao Wang,et al.  Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease , 2013, Neurobiology of Aging.

[8]  P. Kind,et al.  The Subtype of GluN2 C-terminal Domain Determines the Response to Excitotoxic Insults , 2012, Neuron.

[9]  R. Morris,et al.  Conditional Inactivation of Presenilin 1 Prevents Amyloid Accumulation and Temporarily Rescues Contextual and Spatial Working Memory Impairments in Amyloid Precursor Protein Transgenic Mice , 2005, The Journal of Neuroscience.

[10]  D. Choi,et al.  4 – Cytotoxicity in Murine Neocortical Cell Culture , 1993 .

[11]  R. Metherate,et al.  A Role for Synaptic Zinc in Activity-Dependent Aβ Oligomer Formation and Accumulation at Excitatory Synapses , 2009, The Journal of Neuroscience.

[12]  K. Reymann,et al.  Early neuronal dysfunction by amyloid β oligomers depends on activation of NR2B-containing NMDA receptors , 2011, Neurobiology of Aging.

[13]  J. Mornon,et al.  p3 peptide, a truncated form of Aβ devoid of synaptotoxic effect, does not assemble into soluble oligomers , 2008, FEBS letters.

[14]  Christian Rosenmund,et al.  Synaptic NMDA receptor channels have a low open probability , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  D. Dickstein,et al.  Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease Model , 2003 .

[16]  Yansu Guo,et al.  Iron is a potential key mediator of glutamate excitotoxicity in spinal cord motor neurons , 2009, Brain Research.

[17]  R. Nicoll,et al.  Activity differentially regulates the surface expression of synaptic AMPA and NMDA glutamate receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G. Bartzokis,et al.  In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. , 2000, Archives of general psychiatry.

[19]  L. Silvestri,et al.  A potential pathogenetic role of iron in Alzheimer's disease , 2008, Journal of cellular and molecular medicine.

[20]  D. Choquet,et al.  NMDA receptor surface mobility depends on NR2A-2B subunits , 2006, Proceedings of the National Academy of Sciences.

[21]  Xudong Huang,et al.  An Iron-responsive Element Type II in the 5′-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript* , 2002, The Journal of Biological Chemistry.

[22]  J. Thome,et al.  A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms , 2007, Molecular Psychiatry.

[23]  Stefan Vogt,et al.  Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease , 2011, NeuroImage.

[24]  Kim N. Green,et al.  Linking Calcium to Aβ and Alzheimer's Disease , 2008, Neuron.

[25]  S. Younkin,et al.  The Alternatively Spliced Kunitz Protease Inhibitor Domain Alters Amyloid β Protein Precursor Processing and Amyloid β Protein Production in Cultured Cells* , 1996, The Journal of Biological Chemistry.

[26]  S. Mennerick,et al.  Synaptic NMDA Receptors Mediate Hypoxic Excitotoxic Death , 2012, The Journal of Neuroscience.

[27]  Sook Hee Ku,et al.  Influence of multiple metal ions on beta-amyloid aggregation and dissociation on a solid surface. , 2008, Biochemistry.

[28]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[29]  S. Oliet,et al.  Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists , 2012, Cell.

[30]  J. Connor,et al.  HFE mutations and Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.

[31]  A. Buisson,et al.  Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  Hartwig Wolburg,et al.  Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology , 2006, EMBO reports.

[33]  G. Westbrook,et al.  Synaptic and extrasynaptic NMDA receptor NR2 subunits in cultured hippocampal neurons. , 2006, Journal of neurophysiology.

[34]  E. Mackenzie,et al.  NMDA Receptor Activation Inhibits α-Secretase and Promotes Neuronal Amyloid-β Production , 2005, The Journal of Neuroscience.

[35]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[36]  A. Kirkwood,et al.  Iron Mediates N-Methyl-d-aspartate Receptor-dependent Stimulation of Calcium-induced Pathways and Hippocampal Synaptic Plasticity* , 2011, The Journal of Biological Chemistry.

[37]  Jean-François Fisette,et al.  Intronic Binding Sites for hnRNP A/B and hnRNP F/H Proteins Stimulate Pre-mRNA Splicing , 2006, PLoS biology.

[38]  H. Bading,et al.  Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation , 2003, Current Opinion in Neurobiology.

[39]  Joseph A. Helpern,et al.  Histological Co-Localization of Iron in Aß Plaques of PS/APP Transgenic Mice , 2005, Neurochemical Research.

[40]  F. LaFerla,et al.  Role of calcium in the pathogenesis of Alzheimer's disease and transgenic models. , 2007, Sub-cellular biochemistry.

[41]  C. Masters,et al.  Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease , 2010, Cell.

[42]  Alexander Z. Harris,et al.  Extrasynaptic and synaptic NMDA receptors form stable and uniform pools in rat hippocampal slices , 2007, The Journal of physiology.

[43]  Robert J. Williams,et al.  Synaptic NMDA Receptor Activation Stimulates α-Secretase Amyloid Precursor Protein Processing and Inhibits Amyloid-β Production , 2009, The Journal of Neuroscience.

[44]  C. Masters,et al.  Overexpression of Alzheimer's Disease Amyloid-β Opposes the Age-dependent Elevations of Brain Copper and Iron* , 2002, The Journal of Biological Chemistry.

[45]  B. Hyman,et al.  Expression of APP pathway mRNAs and proteins in Alzheimer’s disease , 2007, Brain Research.

[46]  Jerry Kaplan,et al.  Regulation of iron acquisition and storage: consequences for iron-linked disorders , 2008, Nature Reviews Molecular Cell Biology.

[47]  Jim Mintz,et al.  In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI , 1994, Biological Psychiatry.

[48]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal. , 2006, Journal of Alzheimer's disease : JAD.

[49]  A. Buisson,et al.  Activation of Extrasynaptic, But Not Synaptic, NMDA Receptors Modifies Amyloid Precursor Protein Expression Pattern and Increases Amyloid-β Production , 2010, The Journal of Neuroscience.

[50]  H. Bading,et al.  Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders , 2010, Nature Reviews Neuroscience.

[51]  S. Sensi,et al.  Alzheimer's disease, metal ions and metal homeostatic therapy. , 2009, TIPS - Trends in Pharmacological Sciences.